Member Info for crumbs

Think there is some data out there on combo trials taking place and its in the hundreds... but not all combo trials are being run by the best clinicians in the best clinics... that is the BIG difference the top people on the frontline are wanting in on our first combo trial...means a massive amount that especially if the expected data comes in as err expected.

Ahh right well I'd expect and hope we are already worth far more than mcap... So any sale at this point ought to be at a multiple of current sp... thing is though we are only ever worth what a buyer offers so it will only become clear once we do indeed have commercial deals here then we can say oh this is what x company values that one product at this current time etc... anyways the building blocks keep on building up so when that time comes we should be a nice position :)

Has any comparable company in the position Scancell are at this moment ever done that?... only thing I can say is what scancell have does have value and possibly massive value if all the techs are proven effective in trial... one platform Immunobody we can already say has proven value... people suffering from advanced melanoma alive and healthy that once would not have been.... but really we are not for sale and won't be until further trial data is in and by then we could be too valuable for anyone pharma to afford :)

Surely there is no scancell will receive x amount of cash answer to that as it is a team effort of which scancell are a part.. what will be covered are all costs of developing modi3 and any following proof of concept trial... all very good and very validating if and hopefully when team project blueprint win...not sure and doubt that is the liquidity event expected by Hygea though...TF bound to tell you off for emailing 'busy' CH :)

CH's potting shed now :)
doubt there will be any pi AGM revolt I imagine all positive noises will be made there despite an sp of around 10p JC will be disappointed with the market and expect to have a higher sp next year lol... anyways scancell team science are busier than ever and those are the ones that count and will bring us the eventual value...and trials are still green for go.
I was looking to see if scancell will present anywhere in coming months... couldn't find anything but noticed this big New York conference in Sept is full of scancell connected people... which made me realise wow you know what we are very much on the radar where it matters with the scientific movers and shakers in immunotherapy ... http://www.cancerimmunotherapyconference.org/

Lets hope England are good enough keep you from your homework lol

I was happy to read the email... C7 has a bit of a rapport with RG so natural he emails him and yeah now RG has handed over to CH natural CH will take over that role a role he is paid to do and I doubt it cuts into his talking to Roche time but does fulfil his obligations to us pi....good to know all is on track if a little delayed after the long delays we have suffered over the years minor ones can be coped with here.... still looking forward to much more news hope to hear more about new techs... have they come up with a name yet and nano delivery for ImmunoBody is a deal there about to be announced? hope so... ever onwards!

That was the narrative so any hold ups and they will need a new one which would not reflect well...anyways we will see..do seem to be a lot of repeats what is the betting on JC at AGM we are not happy with sp and expect it to be much higher by next AGM lol... well there is Nov to look forward to with grand challenge but hopefully something more coming soon too...

Well they can't use the waiting for Ichor excuse that they were using previously on SCIB1... with SCIB2 I think its to do with nano delivery... probably we are waiting on doing a deal with some third party still deadlines here are a waste of time they may as well say within the next decade :)

Well, they will have all met last week... Ichor were also in Boston...

Well considering scancell are now seriously looking beyond electroporation I do think it is in Ichors interest to indeed offer a better deal to scancell for them to keep using their devices into the future :)

DA we just have to hope those 6 attendees are serious with serious money attached .... notice BioNtech Ichor and Genentech are all at the event.

Don't know but possible and possibly all over to meet FDA?

https://mybio.org/event/member?item_id=7980030

And new platform Immuody or maybe RG lost a B :)...but yes positive tweets 'current' and 'future' partners hmm.. on both platforms.. think we are in for some commercial news this year.

Wonder is it a hint of things to come... a place for moditope not only in TCR sphere but CAR T?...certainly having all the IP on the whole novel approach does no harm :)

Yeah...so basically it is politics

Yes... be interesting to see how it pans out

If it works patient demand kicks right in...it certainly has with Keytruda and not just in approved indications... fact is the market need for treatments is massive due to there not being that many treatments or at least treatments that do actually work for so many that need them...remember Keytruda at best is only effective in 10-30% of patients I've heard it being given to people who are not showing any PD expression at all which does not make sense but there you go...

The end natural selection will sort it all out... either it works or it does not! Trouble is could treatments that will work be kept out by ones that don't just due to the amount of money and power backing the ones that don't ...well I think the market is big and competitive enough to get the best treatments through eventually...what I have noticed is with social media people in dire need all over the world are communicating with each other the power of patients is very real... so I think scancells approach towards advocacy groups is a stroke of tactical genius...